Nonsense mutations in close proximity to the initiation codon fail to trigger full nonsense-mediated mRNA decay

被引:108
作者
Inácio, A
Silva, AL
Pinto, J
Ji, XJ
Morgado, A
Almeida, F
Faustino, P
Lavinha, J
Liebhaber, SA
Romao, L
机构
[1] Inst Nacl Saude Dr Ricardo Jorge, Ctr Genet Humana, P-1649016 Lisbon, Portugal
[2] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA
[3] Univ Penn, Dept Med, Philadelphia, PA 19104 USA
关键词
D O I
10.1074/jbc.M405024200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nonsense-mediated mRNA decay (NMD) is a surveillance mechanism that degrades mRNAs containing premature translation termination codons. In mammalian cells, a termination codon is ordinarily recognized as "premature" if it is located greater than 50-54 nucleotides 5' to the final exon-exon junction. We have described a set of naturally occurring human beta-globin gene mutations that apparently contradict this rule. The corresponding beta-thalassemia genes contain nonsense mutations within exon 1, and yet their encoded mRNAs accumulate to levels approaching wild-type beta-globin (beta(WT)) mRNA. In the present report we demonstrate that the stabilities of these mRNAs with nonsense mutations in exon 1 are intermediate between beta(WT) mRNA and beta-globin mRNA carrying a prototype NMD-sensitive mutation in exon 2 (codon 39 nonsense; beta39). Functional analyses of these mRNAs with 5'-proximal nonsense mutations demonstrate that their relative resistance to NMD does not reflect abnormal RNA splicing or translation re-initiation and is independent of promoter identity and erythroid specificity. Instead, the proximity of the nonsense codon to the translation initiation AUG constitutes a major determinant of NMD. Positioning a termination mutation at the 5' terminus of the coding region blunts mRNA destabilization, and this effect is dominant to the "50-54 nt boundary rule." These observations impact on current models of NMD.
引用
收藏
页码:32170 / 32180
页数:11
相关论文
共 56 条
[1]   Congenital afibrinogenemia:: mutations leading to premature termination codons in fibrinogen Aα-chain gene are not associated with the decay of the mutant mRNAs [J].
Asselta, R ;
Duga, S ;
Spena, S ;
Santagostino, E ;
Peyvandi, F ;
Piseddu, G ;
Targhetta, R ;
Malcovati, M ;
Mannucci, PM ;
Tenchini, ML .
BLOOD, 2001, 98 (13) :3685-3692
[2]   NONSENSE MUTATIONS IN THE HUMAN BETA-GLOBIN GENE AFFECT MESSENGER-RNA METABOLISM [J].
BASERGA, SJ ;
BENZ, EJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (07) :2056-2060
[3]   A coactivator of pre-mRNA splicing [J].
Blencowe, BJ ;
Issner, R ;
Nickerson, JA ;
Sharp, PA .
GENES & DEVELOPMENT, 1998, 12 (07) :996-1009
[4]   Infrequent translation of a nonsense codon is sufficient to decrease mRNA level [J].
Buzina, A ;
Shulman, MJ .
MOLECULAR BIOLOGY OF THE CELL, 1999, 10 (03) :515-524
[5]   Premature termination codons enhance mRNA decapping in human cells [J].
Couttet, P ;
Grange, T .
NUCLEIC ACIDS RESEARCH, 2004, 32 (02) :488-494
[6]   The surveillance complex interacts with the translation release factors to enhance termination and degrade aberrant mRNAs [J].
Czaplinski, K ;
Ruiz-Echevarria, MJ ;
Paushkin, SV ;
Han, X ;
Weng, YM ;
Perlick, HA ;
Dietz, HC ;
Ter-Avanesyan, MD ;
Peltz, SW .
GENES & DEVELOPMENT, 1998, 12 (11) :1665-1677
[7]   An activated 5′ cryptic splice site in the human ALG3 gene generates a premature termination codon insensitive to nonsense-mediated mRNA decay in a new case of congenital disorder of glycosylation type Id (CDG-Id) [J].
Denecke, J ;
Kranz, C ;
Kemming, D ;
Koch, HG ;
Marquardt, T .
HUMAN MUTATION, 2004, 23 (05) :477-486
[8]   Y14 and hUpf3b form an NMD-activating complex [J].
Gehring, NH ;
Neu-Yilik, G ;
Schell, T ;
Hentze, MW ;
Kulozik, AE .
MOLECULAR CELL, 2003, 11 (04) :939-949
[9]   SILENT NUCLEOTIDE SUBSTITUTION IN A BETA+-THALASSEMIA GLOBIN GENE ACTIVATES SPLICE SITE IN CODING SEQUENCE RNA [J].
GOLDSMITH, ME ;
HUMPHRIES, RK ;
LEY, T ;
CLINE, A ;
KANTOR, JA ;
NIENHUIS, AW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (08) :2318-2322
[10]  
HALL GW, 1994, BLOOD, V83, P2031